| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |